Loading clinical trials...
Loading clinical trials...
Multicentre, Open-label, Randomised, Controlled, Parallel Arms Clinical Trial of Induction Chemotherapy Followed by Chemoradiotherapy Versus Chemoradiotherapy Alone as Neoadjuvant Treatment for Locally Recurrent Rectal Cancer - PelvEx II
Conditions
Interventions
Combination drug
Chemoradiotherapy
+1 more
Locations
14
Belgium
UZ Gent
Ghent, Belgium
Amsterdam UMC
Amsterdam, Netherlands
Antoni van Leeuwenhoek
Amsterdam, Netherlands
Catharina Hospital
Eindhoven, Netherlands
University Medical Centre Groningen
Groningen, Netherlands
Leids University Medical Centre
Leiden, Netherlands
Start Date
November 13, 2020
Primary Completion Date
March 1, 2024
Completion Date
March 1, 2030
Last Updated
September 6, 2022
NCT07297004
NCT05877352
NCT00407654
NCT01769222
NCT02528175
NCT01740648
Lead Sponsor
Catharina Ziekenhuis Eindhoven
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions